Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-24 @ 11:15 PM
NCT ID:
NCT00890656
Eligibility Criteria:
Inclusion Criteria:
* Previously treated acute lymphoblastic leukemia (ALL) (including Burkitt's lymphoma) or lymphoblastic lymphoma in relapse or primary refractory;
* No age restrictions;
* Zubrod performance status \</= 3;
* Adequate liver (bilirubin \</= 3mg/dl unless considered due to tumor) and renal function (creatinine \</= 3mg/dl unless considered due to tumor);
* Adequate cardiac function (New York Heart Association (NYHA) \< III as assessed by history and physical examination)
Exclusion Criteria:
* Not Applicable
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00890656
Study Brief:
Protocol Section:
NCT00890656